Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interval Salpingectomy-Can We Have It All?

JAMA network open·2026
Same author

QIM26-304: Integrating Germline Genetic Testing into Oncology Care: Implementation and Evaluation of a Mainstreaming Workflow.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

QIM26-304: Integrating Germline Genetic Testing into Oncology Care: Implementation and Evaluation of a Mainstreaming Workflow.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Frailty and Days at Home After Ovarian Cancer Surgery- A Patient-Centered Outcome for Older Adults.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Association of mental health disorders and all-cause mortality for patients with cancer: Large-scale analysis of University of California Health System Data.

Cancer·2026
Same author

Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.

BMC women's health·2026

Related Experiment Videos

Symptom management in gynecologic malignancies.

Carolyn Casey1, Lee-may Chen, Michael W Rabow

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA, USA.

Expert Review of Anticancer Therapy
|August 3, 2011
PubMed
Summary
This summary is machine-generated.

Gynecologic cancer patients suffer from common symptoms like pain and fatigue, impacting quality of life. Palliative care, integrated early, manages these symptoms to improve patient well-being.

Related Experiment Videos

Area of Science:

  • Oncology
  • Palliative Care

Background:

  • Gynecologic cancer patients face significant symptom burden affecting quality of life.
  • Common symptoms include pain, fatigue, depression, and anxiety.
  • Palliative care aims to relieve suffering and improve quality of life.

Purpose of the Study:

  • To review the epidemiology, assessment, and management of symptoms in gynecologic oncology.
  • To highlight the role of palliative care in comprehensive cancer treatment.

Main Methods:

  • Literature review on symptom management in gynecologic cancer.
  • Focus on common symptoms: pain, fatigue, nausea/vomiting, lymphedema, ascites, depression, anxiety, sexual dysfunction.

Main Results:

  • Symptom burden negatively impacts quality of life for gynecologic cancer patients.
  • Routine symptom assessment and standardized screening tools are crucial for identifying high symptom burden.
  • Palliative care should be integrated concurrently with anticancer therapies.

Conclusions:

  • Effective symptom management is integral to gynecologic cancer care.
  • Early integration of palliative care improves patient outcomes and quality of life.
  • Further review of specific symptom management strategies is warranted.